PHG0026-Human FGF-basic (FGF-2/bFGF) (aa 10-155) and 2 more items

Life Technologies Corporation was awarded a contract by Virginia Polytechnic Institute and State University on September 14, 2026, with a cumulative value of $1,591.93. The contract encompasses the delivery of three distinct biological research products to Tracy Smith at a Virginia location (540-231-5045). The line items include two units of A1370701-CTS N-2 Supplement at $159.74 per unit, one unit of PHG0026-Human Fibroblast Growth Factor-basic (FGF-2/bFGF) (amino acids 10-155) at $554.40 per unit, and three units of A3353501-B-27 Supplement, XenoFree minus vitamin formulation at $239.35 per unit.

The products delivered under this contract represent specialized laboratory reagents and growth factors utilized in cell culture and biological research applications. The PHG0026-Human Fibroblast Growth Factor-basic serves as a recombinant protein essential for cell proliferation and differentiation studies, while the supplement products (A1370701-CTS N-2 and A3353501-B-27) provide defined culture media components necessary for supporting cell growth in research environments. The contract's modest cumulative value and specific quantities ordered indicate this represents a supplemental procurement to support ongoing research initiatives at Virginia Polytechnic Institute and State University.